Skip to main content
Fig. 1 | Molecular Brain

Fig. 1

From: Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation

Fig. 1

Cutaneous features and brain MRI findings of the patient. a Photographs showing several hypopigmented macules on the chest and abdomen (left) and on the back (right) of the patient. b-c. Pre-treatment brain MRI revealing a SEGA (white arrow) located at the foramen of Monro within on coronal T2-weighted imaging (b), multiple cortical tubers (white arrowheads) and a subependymal nodule (black arrowhead) within on axial T2-weighted imaging (c). d-e Post-treatment brain MRI demonstrating size reduction of the SEGA (white arrow) (d), reduced cortical tubers (white arrowheads) and the same size of subependymal nodule (black arrowhead) (e) compared to pre-treatment MRI

Back to article page